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Abstract: The development of intravital Förster Resonance Energy Transfer (FRET) is 
required to probe cellular and tissue function in the natural context: the living organism. 
Only in this way can biomedicine truly comprehend pathogenesis and develop effective 
therapeutic strategies. Here we demonstrate and discuss the advantages and pitfalls of two 
strategies to quantify FRET in vivo—ratiometrically and time-resolved by fluorescence 
lifetime imaging—and show their concrete application in the context of neuroinflammation 
in adult mice. 
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On the one hand, it is widely accepted that FRET is the most common phenomenon used to monitor 
cellular function on a molecular basis in optical imaging. This phenomenon has been extensively 
studied and used in cell cultures or extra-cellularly. As far as extracellular and in vitro conditions are 
concerned, we experienced the development of powerful, elaborate evaluation tools to accurately 
quantify FRET. Ratiometric techniques, including two or more detection channels [1,2], techniques 
based on acceptor photobleaching [3,4] or time-resolved techniques [5–8] (fluorescence lifetime 
imaging (FLIM) or time-resolved fluorescence anisotropy imaging (trFAIM)), have successfully been 
employed to probe molecular and cellular function in vitro. 
On the other hand, understanding and treating diseases implies the understanding of the organism as 
a whole—a highly complex functional network of billions of cells interacting and communicating with 
each other during its lifetime. The specific function of each cell is modified and refined in a dynamic 
manner physiologically or pathologically. Most cellular processes are tightly regulated by a complex 
interplay of protein interactions, modifications, sub-cellular translocations and more. The temporal  
and spatial precision of these events is critical for the function of the whole. The development of 
probes for intravital FRET that offer spatio-temporal detection of these cellular events is necessary to 
examine these molecular mechanisms, in real time and in the genuine context: the living organism.  
In this way, cellular plasticity, crosstalk, metabolic functions and drug responses can be directly 
monitored. Various strategies based on FRET with two or more chromophores as partners for the 
resonance energy transfer have been proposed and applied [9–12]. In this context, the development of 
mouse models encoding FRET biosensors based on fluorescent proteins has opened new opportunities 
for the long-term monitoring of cell and tissue function in living organisms and disease models [13,14]. 
As an alternative, the lenti- or retroviral transfection of cells, followed by their transfer to the living 
animal is a faster solution [15], however, having the disadvantage of a relatively high cellular death 
and a short time span, in which the cells are visible in vivo. The main advantage of cell transfer or 
transplantation is given by the ability to thoroughly characterize the biosensors of interest first under  
in vitro conditions, i.e., cell culture, before employing them in vivo [16]. 
Whereas multi-photon microscopy technology has been extensively used to probe cellular dynamics 
and interactions in living adult mice [17], probing cellular, tissue and organ function proved to be more 
difficult. Numerous technological advances are required to fully take advantage of FRET aiming  
at intravital quantification of cell function. Mainly ratiometric FRET techniques have been  
applied intravitally. In order to fulfill the requirements for dynamic intravital FRET quantification, 
calibration-free techniques are needed, such as FLIM [16,18]. 
Using the example of the CerTN L15 mouse strain, we here comparatively investigate the power 
and the pitfalls of intravital ratiometric FRET, as well as of intravital FLIM-FRET. The CerTN L15 
mouse contains the TN L15 construct, a troponin-C, FRET based calcium biosensor. The FRET 
construct TN L15 contains Cerulean and Citrine as the donor and acceptor, respectively. Probing early 
neuronal dysfunction, before morphological changes occur, meaning early diagnosis, is demonstrated 
on the example of chronic neuroinflammation in these mice. 
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2. Results and Discussion 
2.1. Ratiometric FRET: Intravital Calibration 
The fluorescence intensity images of Cerulean and Citrine (donor and acceptor in the TN L15 
construct) were simultaneously acquired at an 850 nm excitation wavelength. The detection wavelength 
windows were set at 475 ± 20 nm for Cerulean and 535 ± 25 for Citrine. Under these conditions, the 
bleed through of Cerulean on the Citrine detection channel was a portion, α, of the detected Cerulean 
signal, whereas no bleed through of Citrine is expected in the Cerulean detection channel [19]. The 
direct excitation of Citrine at 850 nm is negligible [20]. Both α and the excitation cross-talk were 
additionally verified by simultaneously acquiring the fluorescence signal in a third channel 593 ± 20 nm, in 
healthy mice. 
In order to exclude detector induced artefacts of the signal, we exchanged the (identical) detectors 
of the two channels. We measured on each channel, with both detectors, the same signal. Further, we 
applied the same gain on both channels, but corrected the Cerulean and Citrine signals, ICerulean and 
ICitrine, with the quantum efficiency η of the photomultiplier tube at 475 and 535 nm, respectively. 
Thus, the FRET ratio is expressed in our case as: 
݊ܨ/݀݋݊݋ݎ = ൫(ܫେ୧୲୰୧୬ୣ − ܫୠୟୡ୩୥୰୭୳୬ୢଵ)/ηହଷହ − α ∙ (ܫେୣ୰୳୪ୣୟ୬ − ܫୠୟୡ୩୥୰୭୳୬ୢଶ)/ηସ଻ହ൯
/(ܫେୣ୰୳୪ୣୟ୬ − ܫୠୟୡ୩୥୰୭୳୬ୢଶ)/ηସ଻ହ (1)
or 
ܰܨܴܧܶ = ൫(ܫେ୧୲୰୧୬ୣ − ܫୠୟୡ୩୥୰୭୳୬ୢଵ)/ηହଷହ − α ∙ (ܫେୣ୰୳୪ୣୟ୬ − ܫୠୟୡ୩୥୰୭୳୬ୢଶ)/ηସ଻ହ൯
/ට(ܫେ୧୲୰୧୬ୣ − ܫୠୟୡ୩୥୰୭୳୬ୢଵ) ∙ (ܫେୣ୰୳୪ୣୟ୬ − ܫୠୟୡ୩୥୰୭୳୬ୢଶ)/ηହଷହ ∙ ηସ଻ହ (2)
The values of Ibackground1 and Ibackground2 were calculated as mean values of signal within blood 
vessels (as well as defined areas without Thy1 expression), for each image. We employed two 
normalization strategies: (i) with respect to the donor signal (nF/donor, Equation 1); and (ii) to both 
signals of the donor and acceptor (NFRET) [21–23]. This resulted in different dynamic ranges of the 
normalized ratio, as expected, but all led to the same relative increase between healthy neurons and 
neurons treated with KCl solution (Figure 1, Movie S1). In order to calculate ΔR/R in %—usually 
given in intravital FRET studies [14,15,24]—we refer to the mean values of healthy neurons measured 
under intravital conditions as the minimum ratio and to the values achieved under calcium saturation in 
neurons as the maximum ratio. To determine the ratio value at saturation of neuronal calcium, we 
locally applied on the tissue in the operation field KCl solution (300 µM solution) or glutamate 
solution (100 µM solution). It is known from electrophysiological studies that both glutamate and KCl 
do not lead to complete saturation (100% calcium influx) and that 70% of calcium influx can be 
expected. Ionomycin is more adequate to reach true saturation (100%); however, in the necessary high 
concentrations it induces fast cell death and is not suitable to be used under intravital conditions. 
Ratiometric FRET measurement under intravital conditions is a robust method to acquire relative 
changes of the parameter of interest, in our case, Calcium concentration. Thus, it is principally not 
possible to probe the true, absolute calcium influx in neurons under any conditions. The technique 
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relates the pathological data to qualitative, thus uncertain references like healthy state and reaction to 
chemicals (KCl, glutamate, etc.). 
We used the herein described FRET evaluation setup to measure pathologic neuronal calcium 
increase in chronic neuroinflammation, as well as the effect of various calcium inhibitors (MK801, 
phenytoin, NBQX or nifedipine), as discussed in previous studies [24]. 
 
Figure 1. Intravital ratiometric FRET in healthy CerTN L15 mice. (A) Time-lapse of 
NFRET ratio of a 300 × 300 × 70 µm3 region in the brain stem of a CerTN L15 mouse 
before and during KCl treatment; (B) Cerulean and Citrine (donor and acceptor in TN L15) 
corrected averaged fluorescence signals during KCl treatment as well as averaged 
nF/donor ratio (C) and averaged NFRET ratio (D) time-evolutions. In (D), the blue frame 
defines the minimum NFRET ratio in healthy neurons, while the red frame defines the 
maximum NFRET ratio as given by treatment with KCl. The maximum NFRET ratio was 
validated by treatment with glutamate but is not the maximum reachable NFRET ratio as 
predicted by neurophysiology. The tolerance range for both minimum and maximum 
NFRET values is ≈0.1. CerTN L15 mice are genetically encoding the FRET-based  
Ca2+-biosensor TN L15 in neurons. λexc = 850 nm, λem (Cerulean) = 475 ± 20 nm, λem 
(Citrine) = 535 ± 25 nm. Scale bar = 50 µm. All images are represented as xyz projections. 
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2.2. Challenges in Intravital Ratiometric FRET 
We verified the possibility of detecting the Cerulean and Citrine signals on four (narrower) 
channels, i.e., spectral unmixing, as proposed by Ducros et al. [25] under the conditions required by 
intravital microscopy; that means FRET measurements in 3D over time with a time resolution of  
30–60 s, per 300 × 300 × 50 µm3 (512 × 512 × 26 voxel). The resulting signal-to-noise ratio was 
insufficient to calculate the FRET ratio at an acceptable photon flux, i.e., not a sufficient signal in each 
detection channel, at which the laser itself still does not induce a pathologic calcium increase in 
neurons, massive photobleaching or other tissue photodamage. The use of additional detection 
channels in the range 40–50 nm (three/four instead of two) did not lead to any additional accuracy 
increase in calculating the ratios (nF/donor or NFRET) and, additionally, would interfere with the 
detection of other relevant cellular compartments, like different immune cell subsets. 
The limitations in terms of laser power and acquisition speed imposed by the intravital microscopy 
makes the use of the various highly elaborated FRET techniques (developed for cell culture 
measurements) inappropriate. 
Despite a successful use of ratiometric FRET under specific conditions, several factors limit its 
applicability to deep-tissue in vivo functional imaging. The pitfalls of intravital ratiometric FRET are 
related in the first line to effects of a variable signal-to-noise ratio (SNR) over the 3D images of the 
donor and acceptor signals, respectively. Additionally, photobleaching may limit the application range 
of intravital ratiometric FRET. Here, we investigate these effects and identify the experimentally 
appropriate conditions to minimize them. 
As depicted in Figure 2A, different regions of a 3D image of 300 × 300 × 70 µm3 (517 × 517 × 36 voxel) 
are characterized by different signal-to-noise ratios (SNR), both in the Cerulean channel and in the 
Citrine channel. Moreover, there are severe differences between the depth-dependent SNR (ddSNR) of 
Citrine as compared to Cerulean at various sites due to the differential scattering behavior of the two 
fluorescent proteins. The experiments were performed in a healthy mouse, in which we expect the 
average neuronal calcium concentration to amount to approx. 100 nM all over the tissue. The variable 
ddSNRs of Cerulean and Citrine lead to a variation of the FRET ratio all over the image (Figure 2A). 
The solution to avoid such effects is to choose tissue areas of a homogeneously distributed 
fluorescence signal for both Cerulean and Citrine and to perform the KCl or glutamate calibration in 
each subject (mouse), which is not advisable if you want to investigate your probe without biased from 
artificial excitatory events. The depth-dependent SNR is calculated for each imaging depth as the ratio 
between the fluorescence signal within cellular structures (the background being subtracted) and the 
full-width at half maximum of the background distribution, i.e., background noise. The background is 
considered to be the detected signal within blood vessels and is calculated for each image. 
We demonstrate that different photobleaching of Cerulean and Citrine during 1 h of acquisition, 
every minute, had a negligible effect on the FRET ratio, if the mean laser power was kept under 3 mW 
under the objective lens (peak photon flux 1028 photons/cm2 s at 850 nm). However, considering a 
simple (gross) linear approximation for photobleaching, we could still retrieve a higher photobleaching 
rate for Cerulean as compared to Citrine. The slope of the fitting curve was −1.58 ± 0.54 for Citrine 
and −1.67 ± 0.34 for Cerulean, while the NFRET value increased over time with a slope of 4 × 10−4 
(Figure 2B,C). Since it is known that photobleaching dependence on laser power is highly non-linear, 
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we expect this effect to strongly affect the FRET signal at only slightly higher laser powers or over 
longer acquisition time windows. 
 
Figure 2. Effects of depth-dependent SNR and photobleaching on the NFRET ratio in the 
brain stem of CerTN L15 mice (intravital imaging in healthy and untreated tissue).  
(A) NFRET ratio 3D image (300 × 300 × 70 µm³). Regions of different depth-dependent 
signal-to-noise ratios (ddSNR) show different NFRET ratios although the expected 
neuronal calcium is expected to be the same; (B) Dependence of ddSNR on imaging depth 
for both Cerulean and Citrine fluorescence signals in the two areas labeled in (A);  
(C) Time-dependence of the fluorescence signals of Cerulean and Citrine in Movies S2 and 
S3 and linear approximation of the photobleaching-ind uced time-decay; (D) Time-dependence 
of the corresponding NFRET ratio (Movie S4) as a consequence of photobleaching.  
λexc = 850 nm, λem (Cerulean) = 475 ± 20 nm, λem (Citrine) = 535 ± 25 nm. The mean laser 
power was 8 mW at 850 nm and a 160-fs pulse width, as well as an 80-MHz laser  
repetition rate. 
2.3. Intravital FRET by Donor FLIM: Calibration-Free FRET Quantification 
As discussed by Paul French’s lab [26], time-resolved techniques, such as FLIM, do not need any 
precedent calibration regarding the experimental conditions (laser power, detection efficiency, etc.) to 
determine the boundary conditions for the FRET ratio, which are usually related to a high uncertainty 
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and variability. So far, FRET-FLIM is a calibration-free technique of particular relevance for intravital 
microscopy. By acquiring only the donor fluorescence signal (in our case, Cerulean), the effects of 
differently varying SNRs of Cerulean and Citrine are additionally avoided. However, measuring the 
dependence of FRET ratio by FRET-FLIM on the vital parameter of interest, in our case free calcium 
concentration, is required (Figure 4A). 
In intravital or deep-tissue FRET measurements by donor FLIM, retrieving the cause of 
multiexponential decays of the donor leading to artefacts in the FRET ratio, such as photo-isomerization, 
represents a new challenge [27]. The acquisition of both donor and acceptor fluorescence decays leads 
back to unpredictable effects of a variable ddSNR also affecting the evaluation of the decay curves. 
New FRET constructs based on fluorescent proteins (as proposed by several groups in the last few 
years) with a well-characterized, mono-exponential fluorescence lifetime of the donors are one 
possible solution for this challenge [28,29]. Further efforts are currently being done (and are 
necessary) to translate the expertise on these constructs—gained under in vitro conditions—to 
transgenic mouse technology. 
Here, we investigate the contribution of an additional effect that may cause severe artefacts on 
FRET quantification: the autofluorescence of NADH and NADPH to the fluorescence signal of 
Cerulean, which would lead under intravital conditions to an artificially lower FRET signal since 
enzyme-bound NAD(P)H has a fluorescence lifetime of approx. 2 ns. We investigated acute brain 
slices of adult CerTN L15 mice kept at 4 °C (low metabolic activity, mostly free NAD(P)H, 
fluorescence lifetime ≈ 400 ps) and at 37 °C (mostly enzyme-bound NAD(P)H, fluorescence lifetime ≈ 
2000 ps). The samples were subsequently excited at 760 nm (for NAD(P)H) and at 850 nm (for 
Cerulean). The fluorescence signal was detected at 460 ± 30 nm. Since at 4 °C, the fluorescence signal 
could be detected only after excitation at 850 nm, we conclude that there is no or negligible cross-talk 
between Cerulean and NAD(P)H detection and that FRET quantification is not affected by  
auto-fluorescence (Figure 3A). The fact that in the brain tissue of C57/B6 mice (wild-type mice), any 
specific fluorescence signal is detected after the excitation at 850 nm, in the channel, 460 ± 30 nm is 
supportive for this conclusion (Figure 3B). A possible influence of flavoproteins is excluded, since 
they are emitting at longer wavelengths (green part of the spectrum). 
One of the main challenges in intravital FLIM is finding the appropriate experimental conditions to 
fulfill the requirements of biological and biomedical applications. These are repeated acquisition of the 
same organ field of view for imaging cellular dynamics, typically 150 × 150 × 20 to 500 × 500 × 100 µm3 
(256 × 256 × 11 to 1024 × 1024 × 51 voxel), every 15–60 s, low/negligible photodamage, achievable 
only at low mean and peak excitation powers on the order of 1–10 mW (peak photon flux 1028 photons/cm2 s, 
slightly varying with excitation wavelength and pulse width) and multi-color acquisition, which allow 
for investigating the orchestrated interplay of different cellular compartments [7,30]. These requirements 
are in conflict with the acquisition of a high fluorescence signal, desirable for an artefact-free 
exponential evaluation of fluorescence decays. By using our parallelized TCSPC device (electronics 
dead-time 5.5 ns and parallelized photoelectron gain [18]), we could repeatedly acquire FLIM images 
that we could biexponentially evaluate in a robust, reliable manner. Figure 4B depicts a typical 
intravital 3D FLIM stack (256 × 256 × 11 voxel, 150 × 150 × 20 µm3) acquired within 15 s, an 
example of a biexponentially-evaluated pixel decay curve after 2 × 2 pixel Gaussian noise filtering and 
the distribution of the short (FRET-quenched) and long (unquenched, genuine Cerulean) fluorescence 
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lifetimes over the whole 3D stack. The mean power was 8 mW (5 × 1028 photons/cm2 s at 850 nm) in 
our case. Figure 4A depicts the dependency of the FRET ratio measured by FLIM on the calcium 
concentration, under extracellular conditions, i.e., the isolated TN L15 construct, using the same setup 
as employed for intravital experiments. Under intracellular, in vitro as well as in vivo conditions, we 
could not observe the high FRET ratios acquired at a high free calcium concentration. This is due to 
the fact that free calcium concentrations even in the lower µM range are not possible in the case of  
live imaging. Additionally, Figure 4A depicts fluorescence decay curves at various free calcium 
concentrations together with the mono-exponential approximations of pure unquenched Cerulean  
(0 nM free calcium) and FRET-quenched Cerulean (39 µM free calcium). The fluorescence lifetime of 
unquenched Cerulean agrees with that of CFP ubiquitously expressed under the β-actin promoter in 
mice as measured by us [18] and with the results of others [31]. 
We previously showed that differential scattering behavior of Cerulean and Citrine, respectively, 
leads to differential ddSNRs for the two fluorescent proteins and, thus, to an unreliable FRET ratio in 
deep-tissue and intravital imaging. In the case of deep-tissue and intravital FRET-FLIM, we could 
demonstrate that the fluorescence lifetime of EGFP expressed in neurons (Thy1 mouse) can be reliably 
retrieved at various imaging depths, in brain tissue, as long as the ddSNR is higher than 4 [18]. Here, 
we performed similar experiments on brain slices of healthy CerTN L15 mice and show (Figure 4C) 
that the fluorescence lifetime of Cerulean can be correctly measured at various imaging depths and at 
various ddSNR above a value of 5. 
2.4. Intravital FLIM-FRET in Experimental Autoimmune Encephalomyelitis 
During chronic neuroinflammation, we expect a severe increase of neuronal calcium to precede  
long-term, reversible or irreversible morphological changes of the neuronal processes and somata. 
In order to demonstrate the power of intravital FRET-FLIM, we induced experimental autoimmune 
encephalomyelitis (EAE) in CerTN L15 mice with LysM+ tdRFP expressing cells (immune cells of 
myeloid origin). At the peak of disease, the immune cells invade the central nervous system and build 
the specific lesions, similar to the human disease multiple sclerosis, at which we expect neuronal 
dysfunction and, finally, neuronal death at the lesion site. 
Figure 5 depicts the differences between normal appearing tissue and lesion sites in the brain stem 
of CerTN L15 x LysM+ tdRFP mice affected by EAE, as shown by the accumulation of immune cells 
(red). In this case, it is evident that the increased neuronal calcium over the limit of 1 µM appears only 
at the inflammation sites. Electrophysiological measurements in primary neuronal cultures identified a 
sustained 1 µM intracellular calcium concentration to lead to cell death [32]. 




Figure 3. (A) Fluorescence signal of 300 × 300 µm areas in acute (live) brain slices of  
CerTN L15 mice as measured at 760 and 850 nm, respectively. Detection at λem = 460 ± 30 nm. 
The temperature was set at 4 and 37 °C, to decrease the NAD(P)H metabolism at  
a minimum (4 °C) and to increase it at physiological levels (37 °C), respectively. Since at  
4 °C only free NAD(P)H of a much shorter fluorescence lifetime is detected, the 
fluorescence intensity under excitation at 760 nm is very low (NAD(P)H fluorescence 
representing the integral under the decay curve), whereas under excitation at 850 nm it 
appears at high levels (Cerulean). At 37 °C NAD(P)H is mostly involved in metabolic 
processes, i.e., is bound to enzymes, and shows an up to 10 times longer fluorescence 
lifetime as free NAD(P)H. Under these conditions, both under excitation at 760 nm and at 
850 nm, high fluorescence signals are detected. The laser peak photon flux at the sample 
was kept constant for all experiments to ensure an accurate comparison; (B) Fluorescence 
signal of 300 × 300 µm2 areas in acute (live) brain slices of C57/B6 mice (wild-type)  
as measured at 760 and 850 nm, respectively. Detection at λem = 460 ± 30 nm.  
Scale bar = 100 µm. 




Figure 4. (A) Fluorescence decay curves (right, top) of the isolated construct TN L15 at  
0 nM, 850 nM and 39 µM free calcium. The extreme conditions, i.e., 0 nM and 39 µM free 
calcium are additionally mono-exponentially approximated (left, top and bottom). 
Calibration curve of the biexponential FLIM-FRET ratio of the isolated construct TN  
L15 at various free calcium concentrations (right, bottom). a1 and a2 are the relative 
concentrations of FRET-quenched and unquenched Cerulean as given by the biexponential 
model of the fluorescence decay curve (Supplementary Material); (B) Fluorescence signal 
of Cerulean of a 150 × 150 × 20 µm3 (256 × 256 × 11 voxel) in the brain stem of a healthy 
CerTN L15 mouse (intravital measurement). The graph in the middle depicts an example of 
a decay curve in one of the brightest pixels of the image, including the biexponential 
approximation curve reconvolved with the instrument response function (blue curve), 
together with the final parameters and the corresponding residuals. The lowest graph  
shows the distributions of the fluorescence lifetimes of unquenched and FRET-quenched 
Cerulean over the 3D image at the top. Scale bar = 25 µm; (C) 3D fluorescence intensity 
image of Cerulean (right, top) in a healthy (live) brain slice of a CerTN L15 mouse (300 × 300 
× 120 µm3, 517 × 517 × 40 voxel). ddSNR curve (left, top) as well as corresponding 
dependence of Cerulean fluorescence lifetime on imaging depth (right, bottom) and 
ddSNR (left, bottom). Detection at λem = 460 ± 30 nm. Excitation at λexc = 850 nm, mean 
laser power 8 mW. 




Figure 5. Application of FRET-FLIM in chronic neuro-inflammation to probe neuronal 
dysfunction. (A) Fluorescence intensity image (top) and FLIM-FRET ratio image (bottom) 
in a normal appearing region in the brain stem of a CerTN L15 x LysM tdRFP mouse.  
In the top image, certain subsets of neurons appear green; (B) The same images (intensity 
and FLIM-FRET ratio image) in a region of the brain stem invaded by immune cells (red). 
Image dimensions: 300 × 300 × 40 µm3 (517 × 517 × 21 voxel). λexc = 850 nm.  
λem = 460 ± 30 nm. Scale bar = 50 µm. As expected, at regions not affected by 
inflammation, the FRET ratio indicates physiological levels of neuronal calcium, while at 
the lesion site, the neuronal calcium increases at sustained pathological values. 
3. Experimental Procedures 
3.1. In Vivo Two-Photon Laser-Scanning Microscopy (TPLSM) 
The in vivo FRET experiments were performed using a specialized two-photon laser-scanning 
microscope based on a commercial scan head (TriMScope, LaVision BioTec, Bielefeld, Germany). 
We used for detecting the fluorescence signal photomultiplier tubes in the ranges 460 ± 30 or 475 ± 25 
(blue range), 535 ± 25 (green range) and 593 ± 20 nm (red range). Alternatively, we used to detect 
fluorescence in a time-resolved manner a 16-channel parallelized TCSPC detector (FLIM-X16, 
LaVision BioTec, Bielefeld, Germany) in the range 460 ± 30 nm. The excitation wavelength of 
Cerulean was 850 nm (detection at 460 ± 30 or at 475 ± 25 nm), of NADH and NADPH 760 nm 
(detection at 460 ± 30 nm) and of tdRFP in immune cells 1110 nm (detection at 593 ± 20 nm). Citrine 
was detected at 535 ± 25 nm. 
For both intensity and fluorescence lifetime imaging we used an average maximum laser power  
of maximum 8 mW to avoid photodamage. The experimental parameters for FLIM were 160-ps 
histogram bin and a maximum acquisition time for a 512 × 512 image of 5 s to record a fluorescence 
decay stack. The time-window in which the fluorescence decays were acquired was set to 9 ns. 
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3.2. Data Analysis 
FLIM data analysis was performed using self-written software based on Levenberg–Marquardt 
algorithms for non-linear and bilinear fitting (RINIFLIM) [18]. In order to account for the effect of  
the instrument response function, we performed re-convolution after each iteration step during the  
bi-exponential approximation of the Cerulean fluorescence decay. The instrument response function 
was measured as the time-resolved second-harmonics generation signal of KH2PO4 powder. Statistical 
analysis and graphical presentation were carried out with OriginPro (OriginLab, Northampton,  
MA, USA). 3D image reconstruction was performed using Fiji/ImageJ or Volocity (Perkin Elmer,  
Rodgau, Germany). 
3.3. Mice 
The CerTN L15 x LysM tdRFP mouse expresses a FRET-based calcium biosensor in subsets of 
neurons (Thy1 expression cassette) consisting of Cerulean (donor) and Citrine (acceptor) bound to 
troponin C, a calcium-sensitive protein [14]. Additionally, tdRFP is expressed in LysM+ cells using  
Cre-loxP technology [33,34]. The mice are bred on a C57/Bl6 background. 
3.4. Experimental Autoimmune Encephalomyelitis (EAE) 
EAE was induced as previously described [24,35]. Briefly, mice were immunized subcutaneously 
with 150 µg of MOG35–55 (Pepceuticals, Leicestershire, UK) emulsified in CFA (BD Difco, 
Heidelberg, Germany) and received 200 ng pertussis toxin (PTx, List Biological Laboratories, Inc., 
Campbell, CA, USA) intraperitoneally at the time of immunization and 48 h later. 
3.5. Preparation of the Brain Stem Window for Intravital Imaging 
The preparation of the imaging field was similar to our previous description. Animal experiments 
were approved by the appropriate state committees for animal welfare (G0198/11 and G0181/10, 
LAGeSo—Landesamt für Gesundheit und Soziales) and were performed in accordance with current 
guidelines and regulations. 
4. Conclusions 
The possibility of quantifying FRET in living organisms opens unprecedented insight into the 
dynamic nature of cellular function in its genuine context and, thus, is invaluable for biomedical 
research. While ratiometric intravital FRET offers the possibility of increased acquisition speed, it 
allows only for a relative measure of function in tissue, since it necessitates previous in situ calibration 
due to differential scattering (and ddSNR) of the donor and acceptor, respectively. This is a highly 
difficult requirement for intravital imaging and not feasible for disease models. FLIM allows for 
calibration-free measurements, i.e., scattering and, thus, ddSNR independent measurements, and is the 
method of choice for highly accurate organ function quantification under pathogenic conditions with 
the absence of non-excited values. However, since higher signals are required in FLIM, the risk of 
photodamage is higher or the acquisition speed is lowered as compared to ratiometric FRET. If these 
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considerations are taken into account the choice of one or the other technique to perform FRET 
intravitally is determined by the requirements of the specific biomedical application. 
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